Clinical Trials Browser

Phase 1 × Triple Negative Metastatic Breast Cancer × talazoparib × Clear all

NCT02358200 2020-01-10

Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer

Phase 1 Terminated

BreastOther solid neoplasm

Triple Negative Metastatic Breast Cancer